A letter from Jerusalem: some questions on the future of the scientific journal The glory of the sabbatical God instructed the Jews to refrain from farming their land every seventh year in order to allow the soil to regenerate. I must declare that after only a few months at the Hebrew University the idea is not only good for the soil but also for the human mind. The University, Jerusalem and Israel are all proving most nourishing. The sabbatical is indubitably a great invention if used in the right way. A complete break with routine and the (virtual) cessation of everyday professional pressures enable one to pursue all those interests that have all too long been placed on the back-burner. Moreover, one has the opportunity to be exposed to a diverse array of new, challenging ideas.
Having a break from the Journal's editorship, after 6 years with the inevitable deadlines, has proved a welcome relief, although I confess to missing the excitement involved. I am pleased to report that the feeling is contagious. Mike Salzberg, the Acting Editor, admits to enjoying the job. I am grateful to Mike for 'volunteering' to assume the role, as well as to George Halasz for chairing the Editorial Board. Well, what have I been up to as a 'sabbatical editor'? I have taken advantage of the aforementioned opportunity to broaden my horizons by conferring with fellow editors, browsing through other journals, in psychiatry and beyond, and catching up with the literature on such major publishing topics as electronic journals, peer review, the impact factor, scientific fraud, authorship and the information explosion.
Let me share some of the themes that have emerged from this research that I believe warrant further scrutiny. I cannot claim to be an expert on scientific publishing but I have been closely involved in the UK and Australasia with many facets of editing and production stretching back to 1978. I suspect that you will have come across the issues I want to grapple with but, like myself, you may not have had the opportunity to delve into their detail hitherto and therefore not pondered over the implications for the future of journals like our own. You will no doubt have your own thoughts on these themes whether as reader, writer or both. Please do take pen to paper (or whatever they say nowadays) and share your thoughts with colleagues through the correspondence column. As you will see from my comments below, there is ample room for debate.
The place of the reader in scientific publishing
Where to begin? It makes sense to me to start by posing a fundamental question: why do we have scientific journals? Apart from such worthy goals as being entertaining (I place this in a premier position to demonstrate my hope that the era of the stilted, stodgy journal is doomed), provoking, stimulating and educating, the rubric under which all these rest must be the sharing of knowledge. As professionals who claim expertise and skill, we are ethically committed to enhance both aspects through offering to one another our systematic, clinical observations; collations and critical reviews of previously published material; results and comments on scientific research; and the product of the creative imagination in the form of novel hypotheses and theories.
Given these goals, one would have thought that the reader is the key person to satisfy in the effort to achieve them. A number of disconcerting trends in scientific publishing suggest otherwise. Consider firstly the information explosion. Psychiatrists in practice prior to the early 1970s will readily recall, I am sure, the mere handful of core psychiatric journals available then: the American and British, the Archives and Acta Psychiatrica Scandinavica. Psychological Medicine was but a toddler, our Journal a slightly older sibling. No one could have predicted the sheer number of specialty journals that were to find their way onto library shelves over such a short period on the various psychotherapies, trauma, affective disorders, eating problems, psychopharmacology, consultation-liaison psychiatry, neurobiology, substance abuse, psychogeriatrics, child psychiatry, and the like.
This expansion continues unabated. Perusing an issue of Nature recently, I noted reviews of no less than 24 new journals (to add to the estimated 126 000 scientific journals already in existence!). Admittedly, these were in all fields of science but psychiatry claimed two spots: Molecular Psychiatry, specialising in research in molecular biology, and Neuroimage, a journal devoted to brain function. Two advertisements of new journals also caught my eye in the same issue. The Journal of Mental Health Policy and Economics and the International Journal of Geriatric Psychopharmacology have arrived to claim our interest. Every conceivable professional group seeks a place in the sun, it seems, and invariably buttresses its claim with the same opening gambit: 'Given the growing importance of subject X and the unfocused attention paid to X by current journals, we are pleased to inform you that the Journal of X will be launched.. . ' .
The hapless librarian's response is entirely predictable: 'Oh, no, not another new journal, especially when my budget for next year has been slashed and I have to conduct a cull'. The general psychiatrist is apt to retort: 'I can barely keep track of the papers in the one or two journals I now receive which in fact seem to arrive much sooner than expected'. A growing number appear to experience a sense of helplessness, sighing: 'How will I ever cope with this information explosion?'
What underlies the current boom in new journals? I dare say that several factors are at work. A commercial element undoubtedly contributes. One merely has to inspect the catalogues of commercial publishers for the new journals that are unlinked to professional bodies, both their number and titles. The latter embrace some ludicrous subjects, invidious to exemplify here, but tantamount to quasi-subjects. I tend to refer to this dimension of publishing as the production of the 'profit-driven non-journal' . I venture to suggest that the psychiatry would not be any the poorer if they all suddenly succumbed.
It would be cavalier of me to try to explain the intrigues of the market place; instead, let me quote Marc Loudon, an American Professor of Medicinal Chemistry, when he pronounces on the strategy of one giant publisher with no less than 1200 scientific journals. Loudon does not mince his words: '(Their) journals tend to be second and third tier publications, which range from the acceptable to the terrible. None are in the top tier in chemistry, biology and biochemistry, the fields I read in' [ 11. He even refers to some of the publisher's journals in the most unflattering terms ('garbage' for instance) and concludes that his University library would not be harmed if such material was deleted from its holdings. I surmise that we have all compiled lists of our favourite non-journals, those we would urge our librarian to dump at the ear-liest opportunity. I can think of dozens in the psychological sciences whose demise would attract very few mourners.
On the other hand, a sizable proportion of new journals are the result of professional societies, for example psychiatric subspecialities, deeming it necessary to found a scholarly home for their members where they can identify closely with, and actively promote, their chosen interests. The previously cited Molecular Psychiatry and lnternational Journal of Geriatric Psychopharmacology reflect this trend. Part of this development may relate to the preference of some clinicians or researchers to cultivate their relevant knowledge within a well defined arena rather than traipse over the more diffuse terrain of general psychiatry. I can easily illustrate this through my own experience with a 6-year-old journal, Psycho-Oncology. This title was introduced by a group of researchers and clinicians at the cutting edge of the relatively new interface between cancer on the one hand and psychiatry and psychology on the other hand. They would contend that a new vehicle was required to unite professionals working in a clearly identifiable domain; the counter-argument would have it that Psycho-Oncology simply adds to the welter of journals already covering the subject, among them the Journal of Psychosomatic Research, Psychosomatic Medicine, Psychosomatics and General Hospital Psychiatry. I believe the jury is still out on whether we have gained or not from this specialist expansion. If perchance we have, has the reader shared the benefits? (The broader issue of generalist vs specialist in our discipline is ripe for debate; indeed, it would fit snugly into a symposium on current trends in psychiatry. Might the organisers of the 1998 College Congress consider the suggestion as an option for a plenary session?)
Publish or perish is alive and well
Having touched on developments affecting the reader, what issues are emerging as pertinent to the psychiatrist-writer? If we recall the key purpose of a journal as the sharing of knowledge, we might well assume that all contributors share this objective. The career realities confronting them point to a more complex picture. I refer mainly to researchers here but we should remember that many clinical consultants are in the same boat in the sense that all of them are heavily influenced by the 'publish or perish' threat. Their unenviable position is well captured in the common Israeli expression of Ein Breira, no choice. And it is no longer mere publication that is called for. One has to publish frequently and in journals with a high impact factor.
The repercussions of this gratuitous pressure are little short of disastrous. Instead of creative absorption and authentic curiosity in the research work at hand, the incessant pre-occupation is with the number of papers that can be extracted from the results of the studies and how they can be channeled into journals with high impact factors (IF). The IF has become the name of the game of late. A brief word about this phenomenon is a prerequisite to what follows. Introduced in the 1960s primarily as a service to librarians for their decision-making regarding which journals to include in their holdings, it has come to be used, inter alia, by fundors as a means to assess an applicant's research track record. Specifically, the greater the number of articles published in journals with high IFs, the greater the scientific credit accorded to the applicant by the fundor.
But what precisely is the IF, and should it be used in the way just described? To quote its inventor, Eugene Garfield, the founder of the Institute for Scientific Information (ISI) which compiles the data, it is a 'measure of the frequency with which the "average article" in a journal has been cited in a particular year or period' [ 2 ] . Our Journal, for example, achieved an IF of 0.857 in 1996 (the most recent available), a figure derived from the total citations of the Journal's articles in 1994-1995 in publications covered by the IS1 (a mere fraction of the world's literature) divided by the number of articles published in the Journal during those two years. This ratio obviously eradicated a bias of an absolute citation count which would favour the larger or more frequently published journal.
How reliable is this datum? It would be prudent to pay heed to the caveat emptor of Garfield himself; he comments that it is a 'gross approximation' of the prestige of a journal and needs to be considered in conjunction with other factors like 'peer review, productivity and subject specialty citation rates' [ 2 ] . Since many factors affect citation rates, Garfield adds, we should not depend on the IF alone in appraising the value of a journal. One obvious factor is the average number of references listed at the end of the average article. We at the Journal for instance have an unwritten policy that stacking the reference list with superfluous citations is unwelcome in that it serves little scholarly purpose and, more pragmatically, takes up valuable space. With modem bibliographic services accessible at the press of a button, we could all produce impressive lists, but would we have studied each article conscientiously in order to conclude whether it is an essential citation for the article being prepared? I doubt it. Better a focused selection which the reader needs to enhance his appreciation of the work at hand.
The problem has extended well beyond the arbitrariness of length. We learn from the grapevine among authors that citing one's own references and those of colleagues in the pursuit of maintaining the high IF of ones's preferred journal is another game to be added to the catalogue.
Let me briefly list other influences of IFs. Regional journals may have a low impact for obvious reasons. New journals will naturally rate poorly while they seek a readership. Interdisciplinary journals are often the most frequently cited while review articles do better than standard research reports since the review tends to be used globally to refer to earlier literature (review journals obviously gain high IFs). Finally, citation counts do not differentiate between letters, case reports, reviews and research reports. I could devote several columns to this area and must confess that I am tempted to do so since I believe that the IF is being misapplied; nothing can substitute for conscientious and necessarily time-consuming evaluation of an article independent of its place of publication and indeed of whom its authors happen to be. Let me rather refer you to Professor Per Seglen, an expert on the subject; his recent critique entitled 'Why the impact factor of journals should not be used for evaluating research' [3] is a solidly grounded argument.
Who is an author?
Having got this matter off my chest (as you can see, I have not had any hesitation in declaring my bias) I want to turn to one final noteworthy theme that affects psychiatrists as writers: namely, the thorny issue of what is the definition of an author. This may seem an odd topic to raise but it is in a state of considerable turbulence at present and likely to be modified before long. All readers will have observed that authorship lists are growing by the day. I counted no less than 51 names listed as authors of an article on genome sequencing of Archaeoglobus fulgidus in a recent issue of Nature (a large team by any account, but I seem to recall even longer author lists).
The International Committee of Medical Journal Editors has struggled to establish criteria for authorship and suggested that each author should have con-tributed adequately so as to take responsibility for the content. Given that authorship is a key facet of academic life, it should not surprise us that this convention may be stretched in diverse ways. The inclusion of a Departmental or laboratory head in an authorship list solely by dint of the position held is commonplace, as is the listing of those whose task was limited to having helped to obtain research funds.
Richard Smith, the editor of the British Medical Journal, has recently argued for dumping the entire concept of authorship and replacing it with a system of 'credits' [4] . The idea was in fact first mooted in 1966 by Drummond Rennie, a deputy-editor of Journal of the American Medical Association, when he advocated a schema in which the dramatis personae involved in a research presentation would be awarded credits based on their particular contributions. Much like film credits (director, producer, editor, and the like), we would spell out the specific roles played by participants in the creation of a paper (eg. fund-raiser, writer, statistician and data analyst). Readers could then determine for themselves the relative value of the various contributions.
Other options are not readily forthcoming, although reverting to a bygone era when it was 'accepted that a good researcher (could) write one to three valuable research articles a year' [ 5 ] is appealing, albeit fanciful. Imagine the spare time that would become available to write the best paper possible, think a lot more about the work being undertaken generally, devote more time to good quality teaching, and, who knows, take the opportunity to read some of those potentially interesting papers and books fast piling up on the side of one's desk.
Van Loon [4] recommends journal editors pursue policies that deter authors from submitting papers 'aimed at earning credits' rather than disseminating knowledge. This may already be a de facto policy in some quarters. Some editors regard their journal's prestige in terms of the rejection rate. The Lancet and British Medical Journal accept about 15% of the material submitted to them. The American Journal of Psychiatry is fast catching up. Our Journal can even 'boast' of a 45% rejection rate. One can easily feel cynical about this trend but it may prove a blessing in disguise.
Editors of key psychiatric journals could easily mount a policy whereby authors are requested to submit only those papers to which they have made a significant contribution. They might be encouraged to be content with publishing a lesser number each year, but at the same time, papers of which they are immensely proud. Another simple step might be to limit the number of authors to three or four unless compelling reasons were provided to warrant a greater number.
Time for action?
Some fellow editors with whom I have shared my concerns concur with me that thinking about the portents in the world of scientific publishing tends to induce a state of helpless pessimism; one colleague has starkly predicted a scientific culture in which ' pseudo-knowledge is peddled in non-journals with profit as the dominant motive'. Pretty strong stuff. But the issues I have raised in this 'letter' are not for editors alone and should stir everyone committed to the gaining and sharing of new knowledge. In psychiatry, I believe we would all profit from a concerted effort at confronting two basic questions: what is the optimal function of our professional journals, and how can this be best accomplished?
While preparing this 'letter' I have delved into the deeper recesses of my activist self in order to seek remedies for the weighty difficulties I have identified. But this may be premature. A first step is called for, namely an exchange of views as to what is the essence of the difficulties. We need to use a clinical approach; what is the diagnosis, and the likely prognosis if we do not apply any treatment? We can only formulate optimal treatment plans after clarifying the first two aspects.
Perhaps I am being unduly influenced by the remarkable atmosphere that envelops anyone living in Jerusalem, the scene of so many dire prophecies and their fulfilment. Perhaps that gloomy of prophets, Jeremiah, has me in his grip! Ironically, he refers in Chapter 8, Verse 8 to the '. . .false pen of the scribes'. Is this a sign to goad us into action? I am an optimist at heart and would much prefer to end on a hopeful note. Indeed, I take encouragement from an idea Mike Salzberg has proffered (I am not sure how seriously) of devising the 'Declaration of Melbourne 2000'. Now this may seem a trifle grandiose but, in the spirit of other declarations, like that of Helsinki on ethical aspects of conducting research, it is not too fanciful to imagine formulating ethical principles to guide the lofty objective of sharing new knowledge with a sense of integrity, and thus infusing psychiatric publishing with a dedication to those values we prize. As a College with a fine code of ethics, could we be challenged to take the initiative?
